Welcome to our dedicated page for Hinge Health SEC filings (Ticker: HNGE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hinge Health, Inc.'s SEC filings document its public-company reporting as an emerging growth company operating a technology platform for musculoskeletal care. Its Form 8-K filings cover quarterly and annual financial results, furnished earnings releases, supplemental investor materials, non-GAAP financial measures and reconciliations, and Regulation FD disclosures.
The company’s filings also record governance and capital-structure matters, including proxy materials for director elections and auditor ratification, board appointments and committee assignments, share repurchase authorization, Class A common stock disclosures, and post-IPO lock-up matters. These documents provide formal disclosure on operating results, stockholder voting matters, board oversight, capital allocation and securities-related events.
Hinge Health, Inc. director Leslie Kristina M received an equity compensation award in the form of restricted stock units. On June 3, 2026, she was granted 3,837 shares of Class A Common Stock at a reference value of $52.12 per share.
The award consists of 3,837 restricted stock units (RSUs) issued under the company’s Non-Employee Director Compensation Program for board service. These RSUs vest according to the award’s terms, and each RSU converts into one share of Class A Common Stock upon settlement. Following this grant, Leslie Kristina M directly owns 31,587 shares of Class A Common Stock.
Hinge Health, Inc. held its 2026 annual stockholder meeting on June 3, 2026, where investors voted on board composition and the company’s auditor. The company’s multi-class structure gave one vote per Class A share, fifteen votes per Class B share, and votes for Series E preferred based on convertibility.
Stockholders elected Teddie Wardi to the board with 276,921,911 votes for and 14,888,631 votes withheld, and Tyler Sloat with 291,330,022 votes for and 480,520 votes withheld, plus 14,168,983 broker non-votes for each. They also ratified Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2026, with 305,789,374 votes for, 121,058 against, and 69,093 abstentions.
Hinge Health, Inc. director Robinson Elliott filed a Form 4 reporting open-market sales of Class A Common Stock by funds affiliated with Bessemer Venture Partners. On June 1, 2026, Bessemer Venture Partners X L.P. sold 51,580 shares and Bessemer Venture Partners X Institutional L.P. sold 48,420 shares at a weighted average price of $61.08, executed in multiple trades between $60.82 and $61.44. On June 2, 2026, the same funds sold 10,121 and 9,500 shares, respectively, at a weighted average price of $60.34, in trades between $60.00 and $60.74. Elliott is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in these holdings and expressly disclaims beneficial ownership beyond any indirect pecuniary interest.
Hinge Health, Inc. executive chairman and co-founder Gabriel M.I. Mecklenburg reported mixed insider activity that combines a derivative conversion with open-market sales of Class A Common Stock. On June 1, 2026, he converted 83,334 shares of Class B Common Stock into the same number of Class A shares and then sold 83,334 Class A shares in multiple open-market trades under a pre-arranged Rule 10b5-1 trading plan. The reported sale prices ranged from the mid‑$50s to low‑$60s per share, including trades around $55.21 to $62.07. Following these transactions, he held 83,334 Class A shares directly, along with indirect holdings of Class B Common Stock through a family trust and a GRAT that are convertible into 383,592 and 857,880 Class A shares, respectively.
Hinge Health, Inc. Chief Financial Officer James Budge reported a routine tax-withholding transaction involving 9,986 shares of Class A common stock at $56.21 per share. These shares were relinquished and cancelled so the company could cover his federal and state tax obligations from vesting restricted stock units. Following this disposition, he directly holds 435,400 shares of Class A common stock.
Hinge Health, Inc. President James Pursley reported a tax-related share withholding. On the transaction date, 6,326 shares of Class A Common Stock were relinquished at a value of $56.21 per share to cover federal and state tax withholding from the vesting of restricted stock units. These shares were cancelled by the company, which agreed to satisfy the tax obligations. After this exempt disposition, Pursley directly holds 773,897 shares, so his overall ownership remains substantial and the event reflects a routine, non-market transaction rather than an open-market sale.
HNGE notices proposed sales of Class A shares by affiliated holders under Form 144. The excerpt lists multiple sale filings on 05/07/2026 and 05/08/2026, showing transactions by Bessemer Venture Partners X LP and Bessemer Venture Partners X Institutional LP for listed share amounts and cash proceeds.
The excerpt includes examples of holders and amounts, including Bessemer Venture Partners X LP: 154,740 shares for $8,475,228.33 and 103,160 shares for $5,690,563.60. The filing type is a Form 144 notice of proposed sale and the primary action is sale of existing shares.
HNGE notice of proposed resale under Rule 144 by affiliated Bessemer entities of multiple blocks of Class A common stock. The excerpt lists transactions dated 05/07/2026 and 05/08/2026 showing planned sales of shares and corresponding cash amounts by Bessemer Venture Partners X LP and Bessemer Venture Partners X Institutional LP.
Hinge Health, Inc. Chief Financial Officer James Budge reported open-market sales of a total of 5,907 shares of the company’s Class A Common Stock on May 26, 2026. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan.
The sales occurred in three tranches: 3,507 shares at a weighted average price of $53.3237, 2,100 shares at $54.3733, and 300 shares at $55.2233. All reported holdings are direct, and no option exercises or derivative transactions are included in this filing.
Hinge Health, Inc. president James Pursley reported selling a total of 16,000 shares of Class A Common Stock in open-market transactions. The sales occurred on May 26, 2026 at weighted average prices of about $53–$55 per share, with individual trades recorded at $53.29, $54.29 and $55.16.
After these transactions, Pursley directly holds 780,223 shares. A footnote explains that at least one line of sales was effected under a Rule 10b5-1 trading plan adopted on June 13, 2025, and that his holdings include 781 shares acquired on May 15, 2026 through the company’s employee stock purchase plan.